BamSEC and AlphaSense Join Forces
Learn More

K-V Pharmaceutical Co

Formerly NYSE: KV.A

Material Contracts Filter

EX-10
from 8-K 4 pages K-V Pharmaceutical Company 2013 Incentive Compensation Plan Form of Equity Bonus Agreement
12/34/56
EX-10
from 8-K 8 pages K-V Pharmaceutical Company 2013 Incentive Compensation Plan Form of Option Award Agreement Notice of Option Grant
12/34/56
EX-10
from 8-K 3 pages K-V Pharmaceutical Company Non-Employee Director Compensation Policy
12/34/56
EX-10
from 8-K 37 pages K-V Pharmaceutical Company 2013 Incentive Compensation Plan
12/34/56
EX-10.1
from 8-K 9 pages Settlement Agreement and Release
12/34/56
EX-10.31
from 10-K 4 pages January 17, 2012 Hologic, Inc. 35 Crosby Drive Bedford, Ma 01730 Dear Robert
12/34/56
EX-10.16
from 10-K 2 pages Material contract
12/34/56
EX-10.2
from 8-K 9 pages 4510 E. Thousand Oaks Blvd Westlake Village, Ca 91362 June 5, 2012 K-V Pharmaceutical Company 2280 Schuetz Road St. Louis, Missouri 63146 Re: Engagement of Financial West Group as Placement Agent for K-V Pharmaceutical Company Ladies/Gentlemen
12/34/56
EX-10.1
from 8-K 102 pages Common Stock Purchase Agreement Dated as of June 5, 2012 by and Between K-V Pharmaceutical Company and Commerce Court Small Cap Value Fund, Ltd
12/34/56
EX-10.1
from 10-Q 32 pages Supply Agreement
12/34/56
EX-10.2
from 10-Q/A 2 pages [Company Letter Head] May 4, 2011 Patrick Christmas One Corporate Woods Drive Bridgeton, Mo 63044 Dear Patrick: Congratulations! We Are Excited to Have You Join Kv Pharmaceutical Company, and Look Forward to Your Arrival on or Before 06/1/2011. This Letter Provides You With Details of Your Position and Benefits, as Well as Instructions for Beginning Your New Position at Kv. 1. Title: Vice President, General Counsel 2. a Bi-Weekly Salary of $11,538.46 Which Amounts to $300,000.00, Annually. 3. Participation in a Performance Bonus With a Target of 40% of Your Annual Salary With Terms to Be Developed at a Later Date. 4. Stock Options: Pending Board of Director Approval, 40,000 Shares of Kv Common Stock in Accordance With the Terms of the Employee Stock Option Plan. 5. in Accordance With the Company’s Vacation Policy, for Calendar Year 2011 You Will Be Eligible for 20 Days of Vacation, Pro-Rated Based Upon Date of Hire. in the Calendar Year After Hire You Will Be Eligible for 20 Days of Vacation. 6. Participation in Company Fleet Program. 7. Executive Relocation Package to Be Provided Per Company Relocation Policy. 8. Participation in Kv’s Medical, Dental, Disability, and Life Insurance Plans in Accordance With the Terms of Those Plans. 9. Participation in Kv’s Profit Sharing Plan and 401(k) Plan in Accordance With the Terms of Those Plans
12/34/56
EX-10.1
from 10-Q/A 1 page 5. Section 4.(f)(2) and (3) Payments to the Executive Upon Termination of Employment : These Sections Are Hereby Modified to Reflect the Amount Which Shall Be Equal to Two (2) Times the Sum Your Current Base Salary Plus Two (2) Times Your Target Annual Cash Incentive or 60% for Each Year One Is Not Set. 6. You Shall Be Entitled to Participate in the Company’s Executive Fleet Program. All Capitalized Terms Used Herein but Not Defined Shall Have the Meaning Assigned to Them in Your Employment Agreement. Sincerely, /S/ Chris Dumm Chris Dumm Director, Human Resources Acknowledged and Agreed By: /S/ Greg Divis Gregory J. Divis July 25, 2011
12/34/56
EX-10.2
from 10-Q 2 pages [Company Letter Head] May 4, 2011 Patrick Christmas One Corporate Woods Drive Bridgeton, Mo 63044 Dear Patrick: Congratulations! We Are Excited to Have You Join Kv Pharmaceutical Company, and Look Forward to Your Arrival on or Before 06/1/2011. This Letter Provides You With Details of Your Position and Benefits, as Well as Instructions for Beginning Your New Position at Kv. 1. Title: Vice President, General Counsel 2. a Bi-Weekly Salary of $11,538.46 Which Amounts to $300,000.00, Annually. 3. Participation in a Performance Bonus With a Target of 40% of Your Annual Salary With Terms to Be Developed at a Later Date. 4. Stock Options: Pending Board of Director Approval, 40,000 Shares of Kv Common Stock in Accordance With the Terms of the Employee Stock Option Plan. 5. in Accordance With the Company’s Vacation Policy, for Calendar Year 2011 You Will Be Eligible for 20 Days of Vacation, Pro-Rated Based Upon Date of Hire. in the Calendar Year After Hire You Will Be Eligible for 20 Days of Vacation. 6. Participation in Company Fleet Program. 7. Executive Relocation Package to Be Provided Per Company Relocation Policy. 8. Participation in Kv’s Medical, Dental, Disability, and Life Insurance Plans in Accordance With the Terms of Those Plans. 9. Participation in Kv’s Profit Sharing Plan and 401(k) Plan in Accordance With the Terms of Those Plans
12/34/56
EX-10.1
from 10-Q 1 page 5. Section 4.(f)(2) and (3) Payments to the Executive Upon Termination of Employment: These Sections Are Hereby Modified to Reflect the Amount Which Shall Be Equal to Two (2) Times the Sum Your Current Base Salary Plus Two (2) Times Your Target Annual Cash Incentive or 60% for Each Year One Is Not Set. 6. You Shall Be Entitled to Participate in the Company’s Executive Fleet Program. All Capitalized Terms Used Herein but Not Defined Shall Have the Meaning Assigned to Them in Your Employment Agreement. Sincerely, /S/ Chris Dumm Chris Dumm Director, Human Resources Acknowledged and Agreed By: /S/ Greg Divis Gregory J. Divis July 25, 2011
12/34/56
EX-10.40
from S-1 74 pages Asset Purchase Agreement by and Among K-V Pharmaceutical Company, Nesher Pharmaceuticals Inc., Drugtech Corporation and Zydus Pharmaceuticals (USA), Inc. and Zynesher Pharmaceuticals (USA) LLC Dated as of June 17, 2011
12/34/56
EX-10.2
from 8-K 38 pages Pledge and Security Agreement Dated as of March 17, 2011 by and Among K-V Pharmaceutical Company, Each of the Grantors Party Hereto and Wilmington Trust Fsb, as Collateral Agent
12/34/56
EX-10.1
from 8-K 32 pages Purchase Agreement
12/34/56
EX-10.5
from 10-Q 19 pages K-V Pharmaceutical Company Stock Purchase Warrant
12/34/56
EX-10.4
from 10-Q 17 pages K-V Pharmaceutical Company Restated Stock Purchase Warrant
12/34/56
EX-10.3
from 10-Q 17 pages K-V Pharmaceutical Company Restated Stock Purchase Warrant
12/34/56